分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

HSPA6 maintains IMPDH2 phosphorylation to regulate GTP synthesis for driving radioresistance of glioblastoma stem cells

Junlei Yang, Qiankun Lin, Danling Gu, Jiancheng Gao, Yang Liu, Kailin Yang, Zhe Zhu, Chenfei Lu, Daqi Li, Shusheng Ci, Fan Lin, Qianghu Wang, Xu Qian, Yongping You, Qigang Zhou, Xiuxing Wang, Ming Lu, Qian Zhang, Yun Chen, Weiwei Tao, Junxia Zhang

Journal:Cell Reports

IF:7.7

DOI:10.1016/j.celrep.2026.117490

PMID:

Published:2026-06-02

research field:肿瘤学分子生物学癌症干细胞研究信号转导放射生物学

Abstract

Glioblastoma (GBM) is the most common and malignant primary brain tumor. Glioblastoma stem cells (GSCs) promote radioresistance and therapeutic failure, yet the underlying mechanisms remain unclear. Here, we show that heat shock protein HSPA6 promotes GSC radioresistance by enhancing GTP synthesis. HSPA6 is induced by irradiation and reduces GSC sensitivity to radiotherapy. HSPA6 interacts with and activates IMPDH2, a key rate-limiting enzyme in purine biosynthesis, thereby promoting GTP synthesis, reducing DNA damage, and enhancing radioresistance. Mechanistically, HSPA6 recruits ROCK2 to phosphorylate and activate IMPDH2 at S416. Pharmacological inhibition of HSPA6 and IMPDH2 combined with irradiation significantly improves survival in mice bearing GBM. Our study uncovers the crucial role of HSPA6/IMPDH2-mediated GTP synthesis in GSC radioresistance and suggests that targeting this axis may improve radiotherapy efficacy for GBM.

本文使用的Yeasen产品

购物车
客服
转染试用